Clinical trials
beta-Thalassemia trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 3 |
| Enrolling by invitation | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vertex Pharmaceuticals Incorporated | 3 |
| Carelon Research | 2 |
| Celgene | 2 |
| Editas Medicine, Inc. | 2 |
| University Health Network, Toronto | 2 |
| University of British Columbia | 2 |
| Abfero Pharmaceuticals, Inc | 1 |
| Forma Therapeutics, Inc. | 1 |
| Kevin H.M. Kuo, MD, MSc, FRCPC | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| beta-Thalassemia | 20 |
| Anemia, Sickle Cell | 7 |
| Hematologic Diseases | 7 |
| Thalassemia | 7 |
| Hemoglobinopathies | 6 |
| Genetic Diseases, Inborn | 5 |
| Iron Overload | 5 |
| Anemia | 3 |
| Anemia, Hemolytic | 2 |
| Sickle Cell Trait | 2 |
Trials
Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.